mor, incidence rate is approximately 0.07 new cases per million people per year [7,8].All reports generally agree that the tumour frequently presents in the second or third decades of life [8][9][10].Most common clinical characteristics of odontogenic myxoma are swelling of the jaws with only few patients complaining of pain, paraesthesia and ulceration, 28% for pain and 56% for swelling [11].Several studies indicating that there is a higher rate of tumour incidence in the mandible than the maxilla [12][13][14][15], and almost occurring in the premolar and molar region of both jaws and rarely crosses the midline [12,16,17].Cortical expansion and perforation are common findings; however, maxillary myxomas often extend into the sinus [18]. The adequate management of Odontogenic myxoma (OM) is a challenging problem against the high risk of recurrence.The aim of this paper is to report a case of odontogenic myxoma that affected the left maxilla focusing especially on surgical management. Case ReportA 42-year-old female was referred to our department with a complaint of a growing swelling in the area of the canin and premolar molar in his left maxilla that had been noticed a few weeks before. Upon admission, she noticed a swelling measuring about the size of a peanut in the gingiva of upper premolar tooth. That lesion had been excised by a dentist and the histopathologist con- AbstractOdontogenic myxoma (OM) is a benign, locally invasive and aggressive, non-metastasizing neoplasm of the jaw bones. This article presents a rare case of odontogenic myxoma occurring in the maxilla of a 42-year-old female patient with review of the literature emphasizing a huge controversy regarding the surgical management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.